Acta Med. 2012, 55: 130-132

https://doi.org/10.14712/18059694.2015.50

Human Papillomavirus Genotype Spectrum in Studied Group of Montenegrin Women

Danijela Vujoševića, Vineta Vuksanovića,b, Mario Poljakc, Nebojša Jokmanovićd

aCenter for Medical Microbiology, Institute of Public Health, Podgorica, Montenegro
bMedical Faculty, University of Montenegro, Podgorica, Montenegro
cInstitute of Microbiology and Immunology, Faculty of Medicine, Ljubljana, Slovenia
dClinic for Gynecology and Obstetrics, Clinical Center of Montenegro, Podgorica, Montenegro

Received February 7, 2011
Accepted September 5, 2012

References

1. Bernard HU, Chan SY, Manos MM. Identification and assessment of know an novel human papilomaviruses by polymerase chain reaction amplification, restriction fragment lenth polymorphism, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994; 170: 1077–85. <https://doi.org/10.1093/infdis/170.5.1077>
2. Bosch FX, Manos MM, Munoz, et al. Prevalence of Human papillomaviruses in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87: 796–802. <https://doi.org/10.1093/jnci/87.11.796>
3. Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjose S. Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings. J Infect Dis 2010; 202: 1789–99. <https://doi.org/10.1086/657321>
4. De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324: 17–27. <https://doi.org/10.1016/j.virol.2004.03.033>
5. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 2011; 128: 927–35. <https://doi.org/10.1002/ijc.25396>
6. Muñoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J. Med 2003; 348(6): 518–27. <https://doi.org/10.1056/NEJMoa021641>
7. Munoz N, Castellsaque X, Gonzales AB, Gissman L. HPV in the etiology of human cancer. Vaccin 2006; 24: S3: 1–10. <https://doi.org/10.1016/j.vaccine.2006.05.115>
8. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence od eighteen major cancers in 1985. Int J Cancer 1993; 54: 606. <https://doi.org/10.1002/ijc.2910540413>
9. Poljak M, Avšić-Županc T, Seme K. Verižna reakcija s polmerazo – nova raziskovalna in diagnostična metoda v virologiji. Med Razgl 1994; 33: 379–400.
10. Poljak M, Brenčić A, Seme K, et al. Comparative evaluation of the first and second generation Digene Hybrid Capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer. J Clin Microbiol 1999; 37: 796–7. <https://doi.org/10.1128/JCM.37.3.796-797.1999>
11. Poljak M, Seme K, Koren S. The polymerase chain reaction: a critical review of its uses and limitations in diagnostic microbiology. Period Biol 1996; 98: 183–90.
12. Poljak M, Seme K, Gale N. Detection of human papillomaviruses in tissue specimens. Adv Anatomic Pathol 1998; 5: 216–34. <https://doi.org/10.1097/00125480-199807000-00002>
13. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analyses update. Int J Cancer 2007; 121: 621–32. <https://doi.org/10.1002/ijc.22527>
14. Stoler MH. Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int J Gynecol Pathol 2000; 19: 16–28. <https://doi.org/10.1097/00004347-200001000-00004>
15. Wright Jr TC, Massad S, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007; 11: 201–22. <https://doi.org/10.1097/LGT.0b013e3181585870>
16. zur Hausen H. Viruses in human tumors – reminiscences and perspectives. Adv Cancer Res 1996; 68: 1–22. <https://doi.org/10.1016/S0065-230X(08)60350-4>
17. zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009; 384: 260–5. <https://doi.org/10.1016/j.virol.2008.11.046>
18. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA, et al.Genital human papillomav irus infection: incidence and risk factors in acohort of female university students. Am J Epidemiol 2003; 157: 218–26. <https://doi.org/10.1093/aje/kwf180>
19. Philip E, Castle RS, LaMere BJ, et al. Human Papillomavirus (HPV) Genotypes in Women with Cervical Precancer and Cancer at Kaiser Permanente Northern California. Cancer Epidemiol Biomarkers Prev 2011; 20: 946–53.
20. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11: 1048–56. <https://doi.org/10.1016/S1470-2045(10)70230-8>
21. Khan MJ, Castle PE, Lorincz AT , Wacholder S, Sherman M, Scott DR, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV ) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practic e. J Natl Cancer Inst 2005; 97: 1072–9. <https://doi.org/10.1093/jnci/dji187>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive